Title
A positively selected FBN1 missense variant reduces height in Peruvian individuals
Date Issued
2020
Access level
open access
Resource Type
journal article
Author(s)
Asgari S.
Luo Y.
Akbari A.
Belbin G.M.
Li X.
Harris D.N.
Selig M.
Bartell E.
Slowikowski K.
Contreras C.
Galea J.T.
Coit J.M.
Farroñay C.
Nazarian R.M.
O’Connor T.D.
Dietz H.C.
Hirschhorn J.N.
Kenny E.E.
Freeman E.E.
Murray M.B.
Raychaudhuri S.
Publisher(s)
Nature Research
Abstract
On average, Peruvian individuals are among the shortest in the world1. Here we show that Native American ancestry is associated with reduced height in an ethnically diverse group of Peruvian individuals, and identify a population-specific, missense variant in the FBN1 gene (E1297G) that is significantly associated with lower height. Each copy of the minor allele (frequency of 4.7%) reduces height by 2.2 cm (4.4 cm in homozygous individuals). To our knowledge, this is the largest effect size known for a common height-associated variant. FBN1 encodes the extracellular matrix protein fibrillin 1, which is a major structural component of microfibrils. We observed less densely packed fibrillin-1-rich microfibrils with irregular edges in the skin of individuals who were homozygous for G1297 compared with individuals who were homozygous for E1297. Moreover, we show that the E1297G locus is under positive selection in non-African populations, and that the E1297 variant shows subtle evidence of positive selection specifically within the Peruvian population. This variant is also significantly more frequent in coastal Peruvian populations than in populations from the Andes or the Amazon, which suggests that short stature might be the result of adaptation to factors that are associated with the coastal environment in Peru.
Start page
234
End page
239
Volume
582
Issue
7811
Language
English
OCDE Knowledge area
Genética humana
Scopus EID
2-s2.0-85084412633
PubMed ID
Source
Nature
ISSN of the container
00280836
Sponsor(s)
Acknowledgements We thank D. B. Moody for discussions, T. Horn for his feedback on optimizing skin immunohistochemistry and J. N. Katz for advising us on a structured clinical assessment of the musculoskeletal system. The study was supported by the National Institutes of Health (NIH) TB Research Unit Network, grants U19-AI111224-01 and U01-HG009088. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. S.A. was supported by the Swiss National Science Foundation (SNSF) postdoctoral mobility fellowships P2ELP3_172101 and P400PB_183823.
Sources of information: Directorio de Producción Científica Scopus